Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

tDCS in Post-COVID Syndrome: Comparison of Two Targets

  • Read more about tDCS in Post-COVID Syndrome: Comparison of Two Targets

A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

  • Read more about A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.

  • Read more about Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.

Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

  • Read more about Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

COVID-19 Vaccination of Immunodeficient Persons (COVAXID)

  • Read more about COVID-19 Vaccination of Immunodeficient Persons (COVAXID)

Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19

  • Read more about Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19

Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients

  • Read more about Understanding Immunology and Patient Outcomes of COVID-19 in Hospitalized Patients

Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

  • Read more about Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination

  • Read more about Effectiveness of Using Interactive Consulting System to Enhance Decision Aids of COVID-19 Vaccination

Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.

  • Read more about Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 69
  • Page 70
  • Page 71
  • Page 72
  • Current page 73
  • Page 74
  • Page 75
  • Page 76
  • Page 77
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA